Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S-G Kim

Showing results (411-420 of 418) with videos related to

Pageof 42
Sort By:
You have reached the last page of results.This site can display upto 418 results.
Oncogene|July 29, 2014
Gα12 gep oncogene deregulation of p53-responsive microRNAs promotes epithelial-mesenchymal transition of hepatocellular carcinomaY M Yang, W H Lee, C G Lee, et al.
Diabetes Research and Clinical Practice|August 15, 2008
Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetesH J Yoo, H G An, S Y Park, et al.
Clinical Pharmacology and Therapeutics|July 29, 2010
Pharmacokinetics of oltipraz and its major metabolite (RM) in patients with liver fibrosis or cirrhosis: relationship with suppression of circulating TGF-beta1S G Kim, Y M Kim, Y H Choi, et al.
Oncogene|January 17, 2017
Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibitionH S Kim, M Jung, H N Kang, et al.
The Journal of Biological Chemistry|March 30, 2001
Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1S G Cho, Y H Lee, H S Park, et al.
The British Journal of Surgery|May 27, 2020
Role of tumour location and surgical extent on prognosis in T2 gallbladder cancer: an international multicentre studyW Kwon, H Kim, Y Han, et al.
Epidemiology and Psychiatric Sciences|October 20, 2020
Parity and the risk of incident dementia: a COSMIC studyJ B Bae, D M Lipnicki, J W Han, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2026
A Randomized Phase III Trial of Anthracyclines Followed by Taxane versus Taxane Plus Carboplatin as (Neo)Adjuvant Therapy in Patients with Triple-Negative Breast Cancer: KCSG BR 15-1 PEARLY TrialG M Kim, K H Jung, H C Jeung, et al.
Pageof 42

Showing results (411-420 of 418) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 418 results.
Oncogene|July 29, 2014
Gα12 gep oncogene deregulation of p53-responsive microRNAs promotes epithelial-mesenchymal transition of hepatocellular carcinomaY M Yang, W H Lee, C G Lee, et al.
Diabetes Research and Clinical Practice|August 15, 2008
Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetesH J Yoo, H G An, S Y Park, et al.
Clinical Pharmacology and Therapeutics|July 29, 2010
Pharmacokinetics of oltipraz and its major metabolite (RM) in patients with liver fibrosis or cirrhosis: relationship with suppression of circulating TGF-beta1S G Kim, Y M Kim, Y H Choi, et al.
Oncogene|January 17, 2017
Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibitionH S Kim, M Jung, H N Kang, et al.
The Journal of Biological Chemistry|March 30, 2001
Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1S G Cho, Y H Lee, H S Park, et al.
The British Journal of Surgery|May 27, 2020
Role of tumour location and surgical extent on prognosis in T2 gallbladder cancer: an international multicentre studyW Kwon, H Kim, Y Han, et al.
Epidemiology and Psychiatric Sciences|October 20, 2020
Parity and the risk of incident dementia: a COSMIC studyJ B Bae, D M Lipnicki, J W Han, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2026
A Randomized Phase III Trial of Anthracyclines Followed by Taxane versus Taxane Plus Carboplatin as (Neo)Adjuvant Therapy in Patients with Triple-Negative Breast Cancer: KCSG BR 15-1 PEARLY TrialG M Kim, K H Jung, H C Jeung, et al.
Pageof 42